Influence of minor groove binders on the eukaryotic topoisomerase II cleavage reaction with 41 base pair model oligonucleotides

Investigational New Drugs

Volumn 13, Issue 4, 1995, Pages 271-284

  Bell, Achim ^a   Kittler, Leonhard ^a   Löber, Günter ^a   Zimmer, Christoph ^b  

^a FRITZ LIPMANN INSTITUTE   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

cleavage process; CT topoisomerase II; minor groove binder; model oligonucleotide

Indexed keywords

CHROMOMYCIN A3; CONGOCIDINE; DISTAMYCIN A; DNA TOPOISOMERASE (ATP HYDROLYSING);

ARTICLE; AUTORADIOGRAPHY; BINDING SITE; CONTROLLED STUDY; DNA CLEAVAGE; ENZYME INHIBITION; EUKARYOTIC CELL; MITOSIS INHIBITION; MOLECULAR MODEL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DNA BINDING;

ANIMALS; AUTORADIOGRAPHY; BASE SEQUENCE; BINDING SITES; CATTLE; CHROMOMYCIN A3; DISTAMYCINS; DNA; DNA TOPOISOMERASES, TYPE II; ENZYME INHIBITORS; INDOLES; KINETICS; NETROPSIN; OLIGONUCLEOTIDES;

EID: 0029582633     PISSN: 01676997     EISSN: 15730646     Source Type: Journal    
DOI: 10.1007/BF00873133     Document Type: Article

References (46)

1. DNA topoisomerases
2. DNA topoisomerases
3. DNA topoisomerases: why so many?
4. DNA transport by a type II DNA topoisomerase: evidence in favor of a two-gate mechanism
5. The mechanisms of DNA topoisomerases
6. Characterization of the interaction between topoisomerase II and DNA by transcriptional footprinting
7. Eucaryotic topoisomerase II preferentially cleaves alternating purinepyrimidine repeats
8. Minimal DNA requirement for topoisomerase II-mediated cleavage in vitro
9. Double strand DNA cleavage by type II DNA topoisomerase from drosophila melanogaster
10. Cleavage of DNA by mammalian DNA topoisomerase II
11. Mechanism of antitumor drug action: poisoning of mammalian DNA topoisomerase II on DNA by 4′-(9-acridinylamino)-methanesulfon-m-aniside
12. Mode of action of topoisomerase II-targeting agents at a specific DNA sequence: uncoupling the DNA binding, cleavage and religation events
13. DNA topoisomerase poisons as antitumor drugs
14. Topoisomerase-targeting antitumor drugs
15. DNA modification and cancer
16. Effects of the antibiotics netropsin and distamycin A on the structure and function of nucleic acids
17. Structural analysis of drug-DNA interactions
18. Nonintercalating DNA-binding ligands: Specificity of the interaction and their use as tools in biophysical, biochemical and biological investigations of the genetic material
19. DNA structure and perturbation by drug binding
20. Effect of netropsin, distamycin A and chromomycin A3 on the binding and cleavage reaction of DNA gyrase
21. Netropsin and bis-netropsin analogs as inhibitors of the catalytic activity of mammalian DNA topoisomerase II and topoisomerase cleavable complexes
22. Novel linked antiviral and antitumor agents related to netropsin-2: synthesis and biological evaluation
23. DNA minor groove binding ligands: a different class of mammalian DNA topoisomerase I inhibitors
24. DNA recognition by lexitropsins, minor groove binding agents
25. Solution structure of the chromomycin-DNA complex
26. NMR studies of the interaction of chromomycin A3 with small DNA duplexes: binding to GC-containing sequences
27. A unique binding cavity for divalent cations in the DNA-metalchromomycin A3 complex
28. Structure refinement of the chromomycin dimer-DNA oligomer complex in solution
29. Quantitative footprinting analysis of the chromomycin A3-DNA interaction
30. Chromomycin A3 as a blueprint for designed metal complexes
31. Modulation of topoisomerase II catalytic activity by DNA minor groove binding agents distamycin, hoechst 33258, and 4′,6-diamidine-2-phenylindole
32. Simultaneous purification of DNA topoisomerase I and II from eukaryotic cells
33. Studies of the topoisomerase II-mediated cleavage and religation reactions by use of a suicidal double-stranded DNA substrate
34. Molecular recognition between oligopeptides and nucleic acids: DNA binding specificity of a series of bis netropsin analogues deduced from footprinting analysis
35. Nuclear magnetic resonance comparison of the binding sites of mithramycin and chromomycin on the self-complementary oligonucleotide d(ACCCGGGT)2: evidence that the saccharide chains have a role in sequence specificity
36. Oligonucleotide studies of sequence-specific binding of chromomycin A3 to DNA
37. Assignment of DNA binding sites for 4′,6-diamidine-2-phenylindole and bisbenzimide (Hoechst 33258): a comparative footprinting study
38. DNA-sequence dependent binding modes of 4′,6-diamidino-2-phenylindole (DAPI)
39. Distamyicn inhibition of topoisomerase I-DNA interaction: a mechanistic analysis
40. Structural characterization of a 2∶1 distamycin A.d(CGCAAATTGGC) complex by two-dimensional NMR
41. Binding of two distamycin A molecules in the minor groove of an alternating B-DNA duplex
42. Design of a G.C-specific DNA minor groove-binding peptide
43. The molecular origin of DNA-drug specificity in netropsin and distamycin
44. A bifurcated hydrogen-bonded conformation in the d(A.T) base pairs of the DNA dodecamer d(CGCAAATTTGCG) and its complex with distamycin